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Abstract
Introduction Web surveys are often used for utility valuation. Typically, custom utility valuation tools that have not under-
gone psychometric evaluation are used.
Objectives This study aimed to determine the psychometric properties of a metastatic epidural spinal cord compression 
(MESCC) module run on a customizable open-source, internet-based, self-directed utility valuation platform (Self-directed 
Online Assessment of Preferences [SOAP]).
Methods Individuals accompanying patients to the emergency department waiting room in Ottawa, Canada, were recruited. 
Participants made SOAP MESCC health state valuations in the waiting room and 48 h later at home. Validity, agreement 
reliability, and responsiveness were measured by logical consistency of responses, smallest detectable change, the interclass 
correlation coefficient, and Guyatt’s responsiveness index, respectively.
Results Of 285 participants who completed utility valuations, only 113 (39.6%) completed the re-test. Of these 113 partici-
pants, 92 (81.4%) provided valid responses on the first test and 75 (66.4%) provided valid responses on the test and re-test. 
Agreement for all groups of health states was adequate, since their smallest detectable change was less than the minimal 
clinically important difference. The mean interclass correlation coefficients for all health states were > 0.8, indicating at least 
substantial reliability. Guyatt’s responsiveness indices all exceeded 0.80, indicating a high level of responsiveness.
Conclusions To our knowledge, this is the first validated open-source, web-based, self-directed utility valuation module. 
We have demonstrated the SOAP MESCC module is valid, reproducible, and responsive for obtaining ex ante utilities. Con-
sidering the successful psychometric validation of the SOAP MESCC module, other investigators can consider developing 
modules for other diseases where direct utility valuation is needed.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4166 9-018-0092-1) contains 
supplementary material, which is available to authorized users.
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Key Points for Decision Makers 
The Self-directed Online Assessment of Preferences 
(SOAP) tool is freely available, open-source utility-elic-
itation software compatible with modern web browsers, 
including touch-screen mobile devices.
SOAP modules can easily be developed for other clinical 
scenarios.
The SOAP MESCC module is valid, reproducible, and 
responsive for ex ante utility elicitation.
1 Introduction
Quality-adjusted life-years (QALYs) are used to concur-
rently quantify morbidity and mortality within a single 
parameter [1]. For this reason, QALYs can facilitate the 
discussion of risks and benefits during patient counsel-
ling regarding treatment options [2]. To help make funding 
decisions, policy makers may also combine QALYs with 
cost estimates to calculate the incremental cost-effective-
ness ratio [3]. QALYs are calculated using “utilities,” or 
health-related quality-of-life (HRQoL) weights, which are 
obtained by direct valuation or from generic health status 
measures [4].
The choice of utility valuation approach is driven by 
available data. Direct valuation is the classical approach 
in which individuals rate hypothetical health state descrip-
tions using the time trade-off or standard gamble pro-
cedures [5]. These procedures can be used to measure 
utilities for very specific and uncommon health states. 
However, it can be cumbersome to develop valid health 
state descriptions for particular diseases. Alternatively, 
techniques have been developed to convert generic health 
status measures (e.g. EuroQol-5 Dimensions [EQ-5D], 
Short Form-6 Dimensions [SF-6D], or Health Utilities 
Index 3) to utilities [1]. Conversion of generic health state 
measures is advantageous because custom health state 
descriptions are not required. However, utilities can only 
be obtained for health states actually observed in a cohort 
of patients involved in the generic health survey.
Unfortunately, generic health scores have not been col-
lected for many diseases, meaning direct valuation is nec-
essary for measuring utilities. Best practices in economic 
evaluation are to recruit a sample of healthy individuals 
from the general population for utility valuation [6, 7]. 
Traditionally, general population utility valuation has been 
conducted using face-to-face interviews, phone interviews, 
or postal surveys [8]. These forms of survey administra-
tion are time intensive and costly, so web-based surveys 
are increasingly being used [9–22]. Typically, these stud-
ies are conducted using proprietary software, which lim-
its application to other disease contexts. Furthermore, the 
psychometric properties of these propriety software pro-
grams have not been assessed [23].
It is important to determine whether web-based utility 
valuation has acceptable psychometric properties. If this 
mode of administration has acceptable psychometric prop-
erties, rather than building custom software for new utility 
valuation studies, it would be beneficial and efficient for 
investigators to be able to build disease-specific modules 
on a common platform that has been used to develop mod-
ules with acceptable psychometric properties. To meet this 
need, we developed a new open-source (non-proprietary), 
web-based, self-directed utility valuation platform use-
able on major computer systems (including touch-screen 
devices) called the Self-directed Online Assessment of 
Preferences (SOAP) (Appendix 1 and 2 in the Electronic 
Supplementary Material [ESM]). SOAP was designed with 
flexibility in mind and can accept new health state descrip-
tions (modules) with minimal programming.
We decided to first create a SOAP module for metastatic 
epidural spinal cord compression (MESCC), a condition for 
which HRQoL data are limited. MESCC can be treated with 
surgery or radiotherapy, but few high-quality studies com-
pare these interventions using generic health status measures 
for patients. However, surgery and radiotherapy outcomes 
could be compared using utilities obtained by direct valu-
ation of hypothetical probe health state descriptions. The 
European Organisation for Research and Treatment of Can-
cer (EORTC) MESCC working group has developed an 
HRQoL questionnaire for MESCC [24]. Items from this 
questionnaire could be used to generate health state descrip-
tions for a SOAP module.
The objective of this study was to determine whether the 
SOAP platform can be used to develop a valid, reproducible, 
and responsive module for MESCC. For this first applica-
tion of the SOAP platform, we developed a MESCC module 
based on the work of the EORTC and measured psychomet-
ric properties in a general population sample.
2  Methods
2.1  Self‑directed Online Assessment of Preferences 
(SOAP) Platform
Electronic utility valuation protocols are distinguished by 
the form of health state descriptions, assessment approach, 
navigation rules, and auxiliary functions [25]. A detailed 
description of these elements for the SOAP MESCC module 
are provided in Appendix 1 and 2 in the ESM.
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2.2  Metastatic Epidural Spinal Cord Compression 
(MESCC) Module
EORTC phase I development of a MESCC questionnaire 
in Canada found that patients and healthcare providers felt 
that ambulation, urinary continence, pain, and independ-
ence were important HRQoL issues for MESCC. Since 
phase I development was restricted to HRQoL and did not 
specifically consider treatment effects and adverse events, 
we reviewed prospective studies on MESCC to iden-
tify reported outcomes and adverse events [26–29]. The 
EORTC items captured all treatment outcomes identified 
in our review. However, the review identified a large and 
disparate set of adverse effects. To develop a manageable 
decision analytic model, all adverse effects were grouped 
as an “other symptoms” attribute.
A tabular (point-form) presentation of health states 
was chosen as it is preferred by participants, is believed to 
decrease cognitive burden compared with the narrative for-
mat, and produces similar results to the narrative format [30, 
31]. Therefore, we presented health states as a point-form 
list of five dysfunctional attributes: non-ambulatory (N), 
incontinent of urine (I), pain (P), dependent (D), and “other 
symptoms” (S). To reduce the number of potential health 
states, EORTC items were collapsed to indicate the presence 
(+) or absence (−) of the dysfunctional attribute, producing 
32 discrete health states (Appendix 3 in the ESM).
When possible, the phrasing for presence or absence of 
dysfunctional attributes was created using the same EORTC 
items identified in the MESCC module development pro-
cess (Table 1). Items were rephrased to the second person 
and restructured as declarative sentences. Items describing 
feelings or worries were not utilized as we wanted to make 
the health states descriptions as objective as possible. The 
rationale for the specific attribute formulation was as follows:
1. Dependence (D). The two items identified by the 
MESCC working group were combined into one attrib-
ute to highlight the implications of loss of independence. 
The qualifiers “do” and “do not” were added to indicate 
complete function and dysfunction.
2. Lack of ambulation (N). The MESCC working group 
developed a new item that was used as the functional 
level. Again, two items were combined to highlight the 
implications of loss of mobility.
3. Incontinence of urine (I). The item identified by the 
MESCC working group with a qualifier was used as the 
functional level. An item from the EORTC bladder can-
cer module (BLM44) was used to highlight the implica-
tions of loss of bladder control.
4. Pain (P). As MESCC can only occur in the cervical spine 
to the thoracolumbar junction, pain was not differentiated 
by the terms “upper” and “lower” back as was identi-
fied by the MESCC working group. As most patients 
with spine metastasis will have some element of pain, the 
functional state had patients requiring pain medications. 
Use of pain medication served as a qualifier and was 
taken from the EORTC bone metastasis module (BM38).
5. Other symptoms (S). Again, to maintain efficiency, all 
adverse effects were characterized by several common 
adverse symptoms. These items were all taken from the 
core EORTC questionnaire.
Table 1  Health state attributes
EORTC European Organisation for Research and Treatment of Cancer, NA not applicable
a + indicates the presence of a dysfunctional attribute, − indicates an absence
b Codes refer to identifiers in the EORTC item bank
Attributes Symbolsa Items EORTC  codesb
Dependence D− You do not need help with eating, dressing, washing yourself or using the toilet. You 
are not dependent on others
C05, BM49
D+ You need help with eating, dressing, washing yourself or using the toilet. You are 
dependent on others
C05, BM49
Lack of ambulation N− You walk without assistance NA
N+ You have lost mobility because of weakness in your legs. You need to stay in bed or a 
chair (or wheelchair) during the day
BM48, BN48, C04
Incontinence of urine I− You have no trouble controlling your bladder BN50
I+ You need to insert a tube in your bladder or you need to wear a diaper full time, to 
control your bladder
BN50, BLM44
Pain P− You have back pain relieved by pain medications BM31, BM38
P+ You have back pain not relieved by pain medications BM31, BM38
Other symptoms S− You have no other uncomfortable symptoms NA
S+ You have one or more of: nausea, vomiting, shortness of breath, lack of appetite, diar-
rhea
C14, C15, C08, C17
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Valuations were obtained using the standard gamble 
method using a ping-pong search algorithm. In the standard 
gamble, success is typically framed as “perfect” health for 
an undetermined period of time. In this context, this can be 
inferred to be the absence of any dysfunctions. Therefore, 
the fully functional health state (D-, N-, I-, P-, S-) was cho-
sen as the success anchor. To eliminate confusion around life 
expectancy, all scenarios were framed as having a certain 
life expectancy of 5 years; that is, for both the probe health 
scenario and success health scenario, participants were told 
their life expectancy would certainly be 5 years. This was 
the maximum survival reported in a randomized controlled 
trial on treatments for MESCC [27]. Probe health states were 
presented in a random order.
The MESCC module was pilot tested in a sample of 40 
participants to assess acceptability and ease of use. Partici-
pants were asked to rate the SOAP MESCC module using a 
five-point Likert rating for the statement “[t]his website is 
easy to use”, and 92.5% of participants strongly agreed or 
agreed with the statement.
2.3  Subjects
To be compliant with best practice in economic evaluation, 
we sought to conduct a direct utility valuation study with 
a sample of the general population who have not experi-
enced MESCC using the SOAP MESCC module (ex ante 
valuation) [6]. Prior to this general population direct valu-
ation study, psychometric properties of the SOAP MESCC 
module had to be evaluated. To approximate a general 
population sample for this psychometric validation study, 
participants were recruited from the emergency depart-
ment waiting rooms at The Ottawa Hospital, an academic 
hospital in Ottawa, Ontario, Canada. Only patients’ family 
members or friends (i.e. individuals accompanying patients) 
aged ≥ 18 years were eligible to participate. Participants 
were required to be able to read English and have access 
to the internet outside of the hospital. A minimum sample 
size of 50 participants has been recommended in published 
guidelines for reliability and responsiveness evaluations. 
[23]. To ensure robust results, we set the sample size for 
this study at 75.
2.4  Survey Procedures
Participants completed the first survey in the emergency 
department using a touch-screen device. Investigators did 
not assist participants in navigating or completing the sur-
vey. Each participant valued the health state D + N +   I + P+ 
S + , one randomly selected singly dysfunctional health state, 
and another triply dysfunctional health state. Dysfunctional 
elements were nested to ensure a logical ordering of utilities 
for the three health states. For example, if the singly dys-
functional health state was D-N-I + P-S-, the triply dysfunc-
tional health state could include incontinence and two of 
dependence, lack of ambulation, pain, or other symptoms.
Investigators contacted participants via email and/or 
phone 2 days after the initial survey with information to 
access the retest. Participants completed the second survey 
using their personal device. For the retest, participants were 
presented with the same probe health states they completed 
in the emergency room, but states were presented in a new 
random order.
2.5  Statistical Analysis
“Validity” refers to whether a tool under investigation meas-
ures what it is supposed to measure [32]. Specifically, “con-
struct validity” concerns whether results obtained using the 
tool under investigation are consistent with a priori hypoth-
eses [32]. We hypothesized that utility valuations should 
follow the logical ordering of health states, with utility 
valuations following the relationship: singly ≥ triply ≥ fully 
dysfunctional. We considered singly = triply = fully a valid 
response because we could not exclude the possibility of a 
ceiling effect with one dysfunction. Participant responses 
were deemed “valid” if their utilities followed this order. 
The proportion of participants providing valid responses on 
the test and retest was computed.
“Reproducibility” concerns the stability of participants’ 
responses on repeated testing and can be characterized by 
agreement and reliability [32]. “Agreement” quantifies the 
absolute differences in participants’ repeated responses. We 
assessed agreement using the smallest detectable change 
[23]. We classified agreement as adequate if the small-
est detectable change was less than the minimal clinically 
important difference (MCID) [23]. By anchoring to Eastern 
Cancer Oncology Group functional levels, an MCID of 0.05 
for cancer utilities obtained by the three-level EQ-5D (EQ-
5D-3L) has been proposed [33]. This MCID has also been 
used for direct utility valuation by the standard gamble and 
time trade-off of EQ-5D-3L health states [34]. The precision 
of the standard gamble algorithm used in our study was also 
0.05. Therefore, we used an MCID of 0.05 in this study. Sys-
tematic differences between the test and retest sessions were 
quantified using the smallest detectable change calculation. 
“Reliability” concerns the fraction of pooled study variance 
across the repeated tests attributable to differences between 
participants (participant variance) and individual test–retest 
variability (noise) [32]. If responses are stable, the ratio of 
noise to participant variance should be small, and the ratio 
of participant variance to variance for the pooled results 
from test and retest should be high. Reliability accounting 
for systematic differences between the test and retest, strati-
fied for the number of dysfunctions in the health state, was 
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quantified using the intraclass correlation coefficient (ICC) 
using the following categories: < 0.21, slight reliability; 
0.21–0.40, fair reliability; 0.41–0.60, moderate reliability; 
0.61–0.80, substantial reliability; > 0.80, almost perfect reli-
ability [35]. An ICC ≥ 0.70 was considered adequate [23].
“Responsiveness” reflects the ability of a tool to detect 
clinically important changes and can be quantified using 
Guyatt’s responsiveness index [36]. This index is propor-
tional to the ratio of the MCID to the root mean squared 
error of the difference between the test and retest value. If 
test–retest variability is small relative to the MCID, the tool 
is deemed responsive because meaningful changes are of 
greater magnitude than test–retest fluctuation [37]. Values 
of 0.20, 0.50, and 0.80 were interpreted as small, moderate, 
and large levels of responsiveness, respectively [38].
Statistical analysis was performed using the statisti-
cal programming language R [39]. The distribution of 
age (Kruskal–Wallis test) and sex (Chi squared test) was 
compared between participants providing valid and invalid 
responses on the test and retest. We considered logically 
ordered responses to be valid, that is decreasing utilities 
assigned to the singly, triply, and fully dysfunctional states. 
Age was assessed using a one-way analysis of variance 
(ANOVA). Sex was assessed using the Chi squared test. 
Reproducibility, agreement, reliability, and responsive-
ness were only measured for participants providing valid 
responses on both the test and the retest. Since the SOAP 
tool is intended for measuring average utilities from the 
general public, average measures (rather than individual 
measures) of smallest detectable change, ICCs, and Guyatt’s 
responsiveness indices were calculated [40].
3  Results
Of 285 participants who completed utility valuations in 
the emergency department, only 113 (39.6%) completed 
the retest. Of these 113 participants, 92 (81.4%) provided 
valid responses on the first test, and 75 (66.4%) provided 
valid responses on the test and retest (Table 2). The response 
validity pattern was not associated with age (p = 0.2336) or 
sex (p = 0.971) (Table 2). Only data from the participants 
providing valid responses on both the test and the retest were 
used for reproducibility and responsiveness analysis. Seven 
respondents skipped at least one scenario during the test 
and were classified as providing invalid responses. Only one 
respondent skipped one question during the retest, and the 
responses were also classified as invalid.
Agreement for all groups of health states was adequate 
since their smallest detectable change was less than the 
MCID of 0.05 (Table 3). Mean ICCs were all > 0.8, indicat-
ing substantial reliability, and all ICCs were significantly 
greater than the pre-specified threshold of 0.7 (Table 3). 
Guyatt’s responsiveness indices all exceeded 0.80, indicating 
large responsiveness for the utility evaluation (Table 3) [38].
4  Discussion
Utility valuation studies are traditionally conducted using 
face-to-face interviews, phone interviews, or postal surveys. 
These modes of administration have undergone psychomet-
ric validation. Web surveys are increasingly used for utility 
valuation and usually use custom and proprietary valuation 
tools that have not been psychometrically validated. It would 
be beneficial and efficient for investigators to be able to build 
disease-specific modules on a common platform that has 
been used to develop modules with acceptable psychometric 
properties.
We developed a new platform called the SOAP (Appen-
dix 1 and 2 in the ESM). For the first application of this 
platform, we developed a module for MESCC health states. 
The SOAP platform met published benchmarks for repro-
ducibility (both agreement and reliability) and responsive-
ness for utility measurement. This study demonstrated that 
Table 2  Characteristics of 
participants stratified by 
response pattern
Data are presented as N (%), except for age, which is presented as median [interquartile range]
Characteristics Valid → valid Valid → invalid Invalid → valid Invalid → invalid p value
Total 75 (66.4) 17 (15.0) 17 (15.0) 4 (3.6)
Age in years 53.0 [33.5, 61.0] 43.0 [33.0, 48.0] 51.0 [38.0, 62.0] 43.0 [33.25, 52.0] 0.2336
Sex 0.971
 Female 47 (62.7) 11 (64.7) 11 (58.8) 3 (75.0)
 Male 28 (37.3) 6 (35.3) 6 (41.2) 1 (25.0)
Table 3  Agreement, reliability, and responsiveness measurements
CI confidence interval, ICC intraclass correlation coefficient
Number of 
dysfunctions
Smallest 
detectable 
change
ICC (95% CI) Guyatt’s 
responsiveness 
index
Single 0.036 0.879 (0.808–0.923) 1.45
Triple 0.035 0.898 (0.838–0.935) 1.47
Full 0.042 0.826 (0.724–0.890) 1.24
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the SOAP platform can be used to develop modules with 
acceptable psychometric properties.
In total, 81.4% of participants provided valid responses 
on the first test, and 66.4% of participants provided valid 
responses on both the test and the retest. These results 
should be considered in the context of other ex ante valua-
tion studies reported in the literature. We classified a partici-
pant’s responses as valid if their utility valuations decreased 
with increasing dysfunctional attributes in the health state. 
For example, if a participant valued the fully dysfunctional 
health state higher than the single dysfunctional health state, 
their responses were classified as invalid. This definition of 
validity is termed “logical consistency” and has been used in 
traditional general population ex ante utility valuation stud-
ies of EQ-5D-3L health states.
Logical consistency rates for face-to face valuations have 
been reported for the UK and Netherlands [41, 42]. In the 
UK study, 12 pairs of health states per participant could be 
evaluated for logical consistency. The median rate of logi-
cal consistency, per participant, ranged from 83.8 to 91.7%. 
In the Dutch study, 87.6% of participants provided at least 
one pair of logically inconsistent valuations. Postal surveys 
conducted in the USA and New Zealand reported at least one 
logically inconsistent pairing in 88 and 79% of participants, 
respectively [43, 44]. With 81.4% of participants provid-
ing a valid response (28.6% providing a logically inconsist-
ent response), the logical consistency rate for the SOAP 
MESCC module was similar to that of traditional population 
studies. Logical consistency has also been assessed for other 
self-administered general population ex ante utility valuation 
studies of EQ-5D-3L health states over the internet [19, 45, 
46]. Each study reported a logical consistency rate < 70%.
Compared with the SOAP MESCC module, the face-
to-face, postal, and web-based EQ-5D-3L utility valuation 
studies required greater cognitive effort because participants 
rated more health states (between five and ten) that were 
also more complex (five attributes and three levels of dys-
function). Furthermore, these studies did not provide error 
checking, whereas the SOAP MESCC module notified par-
ticipants of a logical error if they rejected a lottery with 
100% of success. Considering these differences, a logical 
consistency rate of 81.4% on the first test with the SOAP 
MESCC module is consistent with the literature.
Valuing MESCC health states using the classical standard 
gamble is problematic for two reasons. First, the classical 
standard gamble uses perfect health as a top anchor, which 
is an unrealistic outcome for metastatic cancer. Second, the 
classical standard gamble considers timeless (i.e. perpetual) 
health states, which is incongruent with the metastatic can-
cer disease process. To make the standard gamble more real-
istic, we characterised perfect health as the absence of dys-
functions and restricted all health states (including the top 
anchor) to a survival period of 5 years. These modifications 
may affect the interpretation of our results relative to classic 
utility assessment.
Utilities are typically estimated for specific health states 
and are used to weight the time in such health states. Con-
sequently, a utility value for a specific state is typically 
considered “timeless,” that is, utilities are usually assumed 
not to change with time spent in a health state [47]. As 
a reflection of this, the duration of time spent in a probe 
health state is not specified in the classical standard gamble 
[5]. For MESCC health states, we were concerned that the 
most severe health states would connote poor survival and 
therefore confound the measurement of HRQoL using the 
standard gamble with quantity of life. To alleviate this dif-
ficulty, we explicitly stated a 5-year duration for each health 
state, which was the longest survival observed in a rand-
omized controlled trial of treatments for MESCC [27]. This 
approach has also been used in other utility valuation stud-
ies for cancer health states [48]. This modification to health 
state descriptions should not affect results because the stand-
ard gamble (and all other utility-elicitation methods) relies 
on the “utility independence” assumption [49]. Under this 
assumption, if a health state has a utility of x , the utility of 
this health state for 5 years should still be x . Unfortunately, a 
systematic review concluded that individuals tend not to sat-
isfy the utility independence assumption with no consistent 
pattern of violation [50]. We are unaware of any algorithm 
to convert utilities for fixed period of time to “timeless” utili-
ties. Consequently, the utilities measured in this study may 
not be directly comparable to utilities obtained using the 
classical standard gamble.
A strength of our study is that we built on the work con-
ducted by the EORTC MESCC working group to ensure 
the attributes in the MESCC module were appropriate and 
representative of the MESCC disease process. A limitation 
of our study is that we did not assess criterion validity by 
comparing utilities obtained by SOAP MESCC and a “gold 
standard” [32]. This could be done by having patients with 
MESCC value their own health using the SOAP MESCC 
module and comparing these utility valuations with those 
derived from a generic health questionnaire. We did not have 
the resources to conduct such a study. Furthermore, meas-
ures of logical validity, reproducibility, and responsiveness 
are more relevant than MESCC criterion validity to inves-
tigators considering developing modules for new diseases.
To our knowledge, this is the first validated open-source, 
web-based, self-directed utility valuation module. For the 
first application of the SOAP platform, we developed a mod-
ule for MESCC health states. We have demonstrated the 
SOAP MESCC module is valid, reproducible, and respon-
sive for obtaining ex ante utilities. Considering the success-
ful psychometric validation of the SOAP MESCC module, 
other investigators can consider developing modules for 
other diseases where direct utility valuation is needed.
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